Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 1
2005 3
2006 2
2007 5
2010 2
2011 1
2012 2
2014 2
2015 1
2017 2
2018 3
2019 3
2020 3
2021 4
2022 5
2023 10
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Iacoboni G, Iraola-Truchuelo J, O'Reilly M, Navarro V, Menne T, Kwon M, Martín-López AÁ, Chaganti S, Delgado J, Roddie C, Pérez A, Norman J, Guerreiro M, Gibb A, Caballero AC, Besley C, Martínez-Cibrián N, Mussetti A, Sanderson R, Luzardo H, Iyengar S, Sánchez JM, Jones C, Sancho JM, Barba P, Latif AL, López-Corral L, Hernani R, Reguera JL, Sureda A, Garcia-Sancho AM, Bastos M, Abrisqueta P, Kuhnl A. Iacoboni G, et al. Among authors: caballero ac. Hemasphere. 2024 May 21;8(5):e62. doi: 10.1002/hem3.62. eCollection 2024 May. Hemasphere. 2024. PMID: 38774657 Free PMC article.
Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.
Iacoboni G, Navarro V, Sesques P, Rejeski K, Bastos-Oreiro M, Serpenti F, Martin Lopez AA, Iraola-Truchuelo J, Delgado J, Perez A, Guerreiro M, Caballero AC, Martinez-Cibrian N, Luzardo Henriquez H, Sanchez Pina JM, Sancho JM, Ghesquieres H, Mussetti A, Lopez Corral L, Hernani R, Reguera JL, Sureda A, Bosch F, Martin Garcia-Sancho A, Kwon M, Subklewe M, Kuhnl A, Bachy E, Barba P, Villacampa G, Abrisqueta P. Iacoboni G, et al. Among authors: caballero ac. J Hematol Oncol. 2024 Oct 29;17(1):102. doi: 10.1186/s13045-024-01608-8. J Hematol Oncol. 2024. PMID: 39468591 Free PMC article.
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.
Caballero AC, Ujaldón-Miró C, Pujol-Fernández P, Montserrat-Torres R, Guardiola-Perello M, Escudero-López E, Garcia-Cadenas I, Esquirol A, Martino R, Jara-Bustamante P, Ezquerra P, Soria JM, Iranzo E, Moreno-Martinez ME, Riba M, Sierra J, Alvarez-Fernández C, Escribà-Garcia L, Briones J. Caballero AC, et al. Blood. 2025 Apr 17;145(16):1788-1801. doi: 10.1182/blood.2024026758. Blood. 2025. PMID: 39841453 Clinical Trial.
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO.
Bailén R, Iacoboni G, Delgado J, López-Corral L, Hernani-Morales R, Ortiz-Maldonado V, Guerreiro M, Caballero AC, Guerra-Domínguez ML, Sánchez-Pina JM, Peña M, Torrent A, Pérez-Martínez A, Bastos-Oreiro M, Reguera-Ortega JL, Martín A, Hernandez-Boluda JC, Martínez-Cibrián N, Sanz J, Briones J, Henriquez HL, Calbacho M, Mussetti A, Sancho JM, Barba P, Kwon M; GETH-TC (Spanish Group of Stem Cell Transplantation and Cell Therapy) and GELTAMO (Spanish Group of Lymphoma and Autologous Stem Cell Transplantation). Bailén R, et al. Among authors: caballero ac. Transplant Cell Ther. 2024 Oct;30(10):988.e1-988.e11. doi: 10.1016/j.jtct.2024.06.022. Epub 2024 Jul 26. Transplant Cell Ther. 2024. PMID: 39069076 Free article.
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study.
Bento L, Gutiérrez A, Martínez C, Ortí Verdet MC, Sorribes M, Caballero AC, Peña M, Pérez A, Jiménez-Ubieto A, Medina L, Bastos-Oreiro M, Caldas-González PF, Navarro B, Salcedo I, Abrisqueta P, Español I, Cornago J, Martín-Moro F, García L, Gómez P, Varela MR, Puente M, Zanabili J, Zudaire T, Zeberio I, Del Campo R, González L, González P, Blázquez C, Rovira J, Sitges M, Franch-Sarto M, Cabero A, Mussetti A, Montoro J, Sampol A, Sureda A, Caballero D, Martín García-Sancho A. Bento L, et al. Among authors: caballero ac. Blood Adv. 2025 Jul 8;9(13):3281-3292. doi: 10.1182/bloodadvances.2024015415. Blood Adv. 2025. PMID: 40163764 Free PMC article.
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature.
García-Cadenas I, Redondo S, Esquirol A, Portos JM, Novelli S, Saavedra S, Moreno C, Garrido A, Oñate G, López J, Caballero AC, Miqueleiz S, Arguello-Tomas M, Briones J, Sierra J, Martino R. García-Cadenas I, et al. Among authors: caballero ac. Transplant Cell Ther. 2023 Jul;29(7):473.e1-473.e6. doi: 10.1016/j.jtct.2023.04.008. Epub 2023 Apr 20. Transplant Cell Ther. 2023. PMID: 37086849 Free article. Review.
Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study.
Bastos-Oreiro M, Iacoboni G, Garcés VN, Caballero AC, Martínez N, Delgado J, Balaguer A, Kwon M, Gonzalez de Villambrosia S, Hernani R, Jimenez-Ubieto A, Bailen R, Zaberio I, Martín García-Sancho A, Barba P. Bastos-Oreiro M, et al. Among authors: caballero ac. Hemasphere. 2025 Feb 4;9(2):e70077. doi: 10.1002/hem3.70077. eCollection 2025 Feb. Hemasphere. 2025. PMID: 39906687 Free PMC article. No abstract available.
55 results